达仁堂(600329.SH)数据源汇总

  • 来源: 自动生成数据源汇总

  • 日期: 2026-05-15

  • 类型: 自动生成数据源汇总

  • 涉及公司: 达仁堂(600329.SH)

  • 涉及主题: 中成药、财务数据、研报线索

  • 一句话摘要: 达仁堂 Tushare、上交所公告、官网抓取的自动汇总入口。

  • 原始链接或文件: 本地生成 / Gangtise 检索

  • 生成时间:2026-05-15T22:14:50

  • 数据源:Tushare Pro、上交所定期报告查询接口、公司官网页面。

公司基本信息

ts_codesymbolnameareaindustryfullnameennamecnspellmarketexchangecurr_typelist_statuslist_datedelist_dateis_hsact_nameact_ent_type
600329.SH600329达仁堂天津中成药津药达仁堂集团股份有限公司Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedDRT主板SSECNYL20010606H无实际控制人其他

Tushare 公司资料

  • ts_code: 600329.SH
  • exchange: SSE
  • chairman: 王磊
  • manager: None
  • secretary: 焦艳
  • reg_capital: 77009.4356
  • setup_date: 19811229
  • province: 天津
  • city: 天津市
  • introduction: 公司是我国中药现代化的开拓者,是中国现代中药制剂技术的摇篮,新中国诸多中药新剂型诞生于此:第一个规模化生产的中药滴丸制剂产品——速效救心丸、第一个中成药片剂——银翘解毒片、第一个中成药酊剂——藿香正气水、第一家通过GMP认证的中药制药企业——第六中药厂等,敢为人先成就公司成为中国现代中药品种资源最丰富的企业集团,拥有22个剂型、599个药品批准文号、122个独家生产品种,包括国家机密品种速效救心丸和国家秘密品种京万红软膏,诸多开先河、补空白、里程碑式的现代中药广受人民赞誉。公司是做大做强祖国医药的坚定拥护者,主动响应国家“十四五”规划号召,2022年5月18日,正式更名为“津药达仁堂集团股份有限公司”,开启公司发展新纪元。“十四五”期间,公司坚定推进“1+5”战略规划,以品牌为引领,突出“三核九翼”,围绕心脑血管、皮肤创面修复、精品国药健康养生3大核心,构建以“速效救心丸”、“京万红软膏”和达仁堂品牌养生健康品类为代表的“核心战力”群;强化呼吸、消化、风湿骨痛等9类产品线协调发展,努力成为现代中药引领者,打造航向蓝海的中药新“航母”,谱写属于公司的新时代绚丽华章。
  • website: www.jydrt.com.cn
  • email: drt600329@163.com
  • office: 天津市南开区白堤路17号
  • employees: 3890
  • main_business: 主要产品:速效救心丸,牛黄降压丸,藿香正气软胶囊,更年安,银翘解毒片,金芪降糖片,紫龙金片,痹祺胶囊,血府逐瘀胶囊,安福隆干扰素,格列齐特,法洛西,特子社复等.
  • business_scope: 中药材,中成药,中药饮片,西药制剂,化学药品原料药制造(3810),化学药品制剂,新草药,医疗器械,营养保健品,化学试剂加工,制造,批发,零售;中药外配加工;卫生用品,健身器材,生活及环境卫生用消毒用品,药物护肤产品,日用百货,服装,鞋帽,家用电器,日用杂品;仓储,宣传广告,技术开发,转让,经济信息咨询服务,房屋租赁;计算机及软件,分析仪器的代购,代销,批发,零售;计划生育用品零售;药用设施租赁;经营本企业自产产品及技术的出口业务;经营本企业生产所需的原辅材料,仪器仪表,机械设备,零配件及技术的进口业务(国有限定公司经营和国家禁止进出口的商品及技术除外);经营进料加工和“三来一补”业务;中药材收购;下列项目由分支机构经营:医疗包装材料,畜用药,饵料添加剂,饲料,饵料,畜禽药品制造,饲料添加剂制造,牲畜饲养,淡水动植物养殖,餐饮,会议服务;定型包装食品,食用油,副食,调料销售;纯净水,卫生用品制造;定型包装饮用水;瓶装纯净水生产经营;饮料;固体饮料;茶饮料生产经营;限分支机构经营:抗生素,生化药品的销售;诊疗科目:医学检验科,中医科,内科专业,儿科专业,皮肤科专业,针灸科专业;生物制品,诊断药品,二类精神药品制剂销售;包装印刷;道路运输;酒(黄酒,酒精),糖,茶,饮料品,蜂产品代购,代销;麻醉药品(限罂粟壳);医疗用毒性药品;蛋白质同化剂,肽类激素的批发;食品,预包装食品,散装食品销售;生物工程及生物制品,化工产品(危险品除外)的研究开发与销售;保健食品批发经营(片剂类,硬胶囊类,袋泡茶类,口服液类);食用农产品批发,零售;科学研究和技术服务业(依法须经批准的项目,经相关部门批准后方可开展经营活动).

市场与估值

{
“latest_trade_date”: “20260515”,
“latest_close”: 42.72,
“return_ytd_pct”: -7.49,
“low_ytd”: 39.01,
“high_ytd”: 47.76,
“return_since_2025_pct”: 39.88,
“low_since_2025”: 29.17,
“high_since_2025”: 50.05,
“return_since_2024_pct”: 24.66,
“low_since_2024”: 24.82,
“high_since_2024”: 50.05,
“latest_pe”: 15.4379,
“latest_pe_ttm”: 15.087,
“latest_pb”: 4.3734,
“latest_ps_ttm”: 6.6098,
“latest_dv_ratio”: 2.9963,
“latest_dv_ttm”: 8.7313,
“latest_total_mv”: 3289843.0888,
“latest_circ_mv”: 2422605.7288,
“latest_turnover_rate”: 0.9137,
“net_mf_amount_20d_wan”: 8126.61
}

财务摘要(亿元 / %)

end_daterevenue_yitotal_revenue_yioperate_profit_yin_income_attr_p_yin_income_yibasic_epstotal_assets_yitotal_liab_yitotal_hldr_eqy_exc_min_int_yimoney_cap_yiaccounts_receiv_yiinventories_yin_cashflow_act_yifree_cashflow_yigrossprofit_marginnetprofit_marginroeroe_waaroadebt_to_assetsrd_exp_yird_exp_to_revenuerevenue_yoyn_income_attr_p_yoy
2019123169.938869.93887.59026.25576.35360.8178.431823.199753.881714.794413.730215.94564.95495.102442.13629.084512.129112.169.808929.57951.3976nannan
2020123166.036566.03657.85186.6176.79660.8682.833923.334958.084119.873315.128114.87726.71424.926239.007210.292211.819811.839.177328.17081.2649-5.579595.77553
2021123169.075469.07548.66687.69147.8688190.670925.532663.644822.831815.369915.25098.5242.119939.914611.391612.63712.649.512828.15961.46774.6018516.237
2022123182.492582.49259.80058.61798.73261.12101.5736.050365.214628.825221.462114.29456.772512.295839.926810.585913.375713.159.720435.49311.506219.423812.0459
2023123182.223182.223110.96989.86719.68711.28102.30135.848666.006921.25221.72715.66526.88495.703844.00511.781415.038815.0610.561335.04231.8465-0.32657514.4954
2024123173.067473.067425.667322.293322.15222.9107.68629.186978.435929.44437.562912.85699.246710.970748.184630.317530.86830.5124.670127.10361.9163-11.1352125.936
2025123149.173449.173424.895921.310221.10752.77116.89745.897970.99510.16439.73211.32974.6107-0.301574.022342.924728.521825.5721.860739.26342.0406-32.7013-4.40985
2026033115.15215.1524.94374.2384.23070.55104.35729.136375.22379.021212.794710.77794.2217-3.326277.706627.92155.79685.84.465327.9198nan-69.1866-80.1128
2025033114.55314.5534.38843.74253.71790.49111.67929.462682.177314.545710.855712.04913.5553-2.905173.856225.5474.66024.663.975126.3816nan-3.95327-11.6918
2024063039.647439.64747.47856.57726.51170.85119.01155.902862.728234.541325.9815.54975.552115.471449.929916.424110.21829.496.73946.97280.4665172.43575.7435
2025063026.505226.505222.696219.276219.23092.5128.53540.523487.849336.270612.257312.22154.87748.701274.672572.555223.184522.319.194931.52730.6185-33.1477193.076

主营构成摘要(亿元 / %)

end_datebz_itembz_sales_yibz_cost_yibz_profit_yicurr_type
20251231东北3.612040.8310182.78102CNY
20251231华东13.64492.8283510.8165CNY
20251231华中5.154481.523483.631CNY
20251231华北18.13365.2440612.8895CNY
20251231华南3.605960.9412712.66469CNY
20251231国外0.4780060.2932130.184793CNY
20251231西北1.425070.3039631.1211CNY
20251231西南3.119360.8087492.31061CNY
20251231商业收入1.455430.9307160.524712CNY
20251231工业收入47.717911.843435.8745CNY
20251231中成药44.61179.6385534.9732CNY
20251231其他主营业务3.662272.664090.998175CNY
20251231西药0.8993920.4714650.427927CNY
20241231东北3.553891.532752.02114CNY
20241231其他业务(地区)0.1424570.05884770.0836093CNY
20241231华东10.18393.841466.3424CNY
20241231华中3.907151.994271.91288CNY
20241231华北46.501426.031720.4697CNY
20241231华南4.14022.157191.98302CNY
20241231国外0.3673220.3542920.0130293CNY
20241231西北1.610440.6462560.964181CNY
20241231西南2.660671.243371.4173CNY
20241231其他业务(行业)0.1424570.05884770.0836093CNY
20241231内部抵销(行业)-3.11098-3.534090.423105CNY
20241231商业收入31.128629.01852.11016CNY
20241231工业收入44.907312.316932.5903CNY
20241231中成药56.573323.628532.9448CNY
20241231其他业务0.1424570.05884770.0836093CNY
20241231其他主营业务4.431522.64531.78622CNY
20241231西药11.920111.52750.392567CNY
20231231东北3.612181.609452.00273CNY
20231231其他业务(地区)0.1623210.04214030.120181CNY
20231231华东9.953944.112095.84185CNY
20231231华中4.710572.093482.61709CNY
20231231华北54.804834.06820.7368CNY
20231231华南3.18491.551251.63365CNY
20231231国外0.4487590.3476370.101123CNY
20231231西北1.748530.7280731.02045CNY
20231231西南3.597131.488722.10841CNY
20231231内部抵销(行业)-4.85336-4.57657-0.276792CNY
20231231商业收入37.615735.62531.99035CNY
20231231工业收入49.298514.949934.3485CNY
20231231中成药58.362324.937433.4249CNY
20231231其他业务0.1623210.04214030.120181CNY
20231231其他主营业务6.730835.135281.59556CNY
20231231西药16.967715.92611.04161CNY
20221231东北3.111291.375991.7353CNY
20221231其他业务(地区)0.1786960.03713740.141559CNY
20221231华东10.07434.243555.83076CNY
20221231华中3.282281.529391.7529CNY
20221231华北58.148238.614319.5339CNY
20221231华南2.671241.437231.234CNY
20221231国外0.3374230.2755670.0618561CNY
20221231西北1.415070.6335620.781504CNY
20221231西南3.274011.40921.86481CNY
20221231中医药特色医院0.04300120.02208310.0209181CNY
20221231内部抵销(行业)-30.8221-30.7937-0.028356CNY
20221231医药制造52.293722.752229.5414CNY
20221231医药流通60.799257.53823.26102CNY
20221231中成药56.520526.63629.8845CNY
20221231其他业务0.1786960.03713740.141559CNY
20221231其他主营业务7.962596.629561.33304CNY
20221231西药17.830716.25321.57744CNY
20211231东北3.143231.371961.77126CNY
20211231其他业务(地区)0.153280.01725720.136022CNY
20211231华东8.240573.416814.82377CNY
20211231华中4.336741.897962.43879CNY
20211231华北47.499431.899115.6003CNY
20211231华南2.018641.123140.895506CNY
20211231国外0.3390510.2859460.0531054CNY
20211231西北1.034060.4717390.562318CNY
20211231西南2.310491.020381.29011CNY
20211231中医药特色医院0.0003279430.000520107-0.000192163CNY
20211231内部抵销(行业)-33.4414-33.4215-0.0198658CNY
20211231医药制造42.833318.539524.2938CNY
20211231医药流通59.529956.36853.16144CNY
20211231中成药46.695422.928923.7665CNY
20211231其他业务0.153280.01725720.136022CNY
20211231其他主营业务6.268965.262211.00675CNY
20211231西药15.957813.29592.66191CNY
20250630中国大陆26.26656.5401319.7263CNY
20250630其他业务(地区)0.05793150.03708480.0208467CNY
20250630国外0.1808080.1358790.044929CNY
20250630中成药24.24555.5356618.7098CNY
20250630其他业务0.05793150.03708480.0208467CNY
20250630其他主营业务1.733470.8746290.858841CNY
20250630西药0.4683280.2657210.202607CNY
20240630中国大陆39.360819.629419.7313CNY
20240630其他业务(地区)0.05370620.02392050.0297856CNY
20240630国外0.2329120.1981350.0347765CNY
20240630中成药30.629312.171318.458CNY
20240630其他业务0.05370620.02392050.0297856CNY
20240630其他主营业务2.731411.767650.963752CNY
20240630西药6.232965.88860.344356CNY
20230630中国大陆40.572321.522319.05CNY
20230630其他业务(地区)0.06336350.01100840.0523551CNY
20230630国外0.2474180.1913130.0561046CNY
20230630中成药30.509112.66617.8431CNY
20230630其他业务0.06336350.01100840.0523551CNY
20230630其他主营业务2.953942.213080.740857CNY
20230630西药7.35676.834540.522159CNY

上交所已下载定期报告

官网抓取

关联页面